FOR UK HEALTHCARE PROFESSIONALS ONLY

About Sevodyne

For more information about Sevodyne, please see the prescribing information.

Welcome to sevodyne.co.uk

Sevodyne (buprenorphine) transdermal patches are indicated for the treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia.1

Available as:

  • Transdermal patch 5 microgram/hr

  • Transdermal patch 10 microgram/hr

  • Transdermal patch 15 microgram/hr

  • Transdermal patch 20 microgram/hr

Sevodyne transdermal patches are bioequivalent to Norspan® (buprenorphine) (Mundipharma GmbH, Germany)/BuTrans® (buprenorphine) (Napp Pharmaceuticals Ltd, UK) buprenorphine transdermal patches.2

Sevodyne could offer significant cost savings to your practice and integrated care system/board (ICS/B).3/4*

Buprenorphine 5 microgram/hr, 10 microgram/hr, 15 microgram/hr and 20 microgram/hr transdermal patches are on the UK Drug Tariffs.3

In addition with Sevodyne you can get:

  • Price guaranteed**

*Based on 69% saving on the cost of buprenorphine transdermal patches in the UK Drug Tariffs. Savings calculated from 2021 spend of 132 Healthboards/CCGs switching their generic and originator brand 5, 10, 15 and 20mcg buprenorphine transdermal patch prescriptions to Sevodyne. **No change in price subject to no material change to the products or of the UK Drug Tariffs until the 2024 PPRS review.
References: 1) Sevodyne SmPCs. 2) Data on file, 1010067149 v5.0 September 2021. 3) Nov 2022 UK Drug Tariffs. 4) Insypher Data :GPPLPD Date Range: May-22 -Jul-2210100831045 v 8.0 October 2022
Adverse events should be reported. Reporting forms and information can be found at:

Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148.
www.mhra.gov.uk/yellowcard

SEV1010311B1_NOV2022

More products available
in this range:
Click to view their
individual websites